HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc.

HEWA
HealthWarehouse.com, Inc.US flagOther OTC
0.12
USD
+0.00
- -
5.11MMarket Cap
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.57
1
1.01
0.44
0.2
0.19
0.26
0.34
0.31
0.34
0.37
0.61
0.87
0.71
Basic EPS, GAAP
-0.54
-0.58
-0.57
-0.31
-0.07
-0.03
-0.04
0.01
-0.02
-0.02
-0.04
-0.01
- -
-0.01
Free Cash Flow per Basic Share
-0.26
-0.29
-0.09
-0.05
-0.03
-0.01
- -
- -
0.01
-0.02
-0.01
0.01
0.02
-0.09
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.84
-1.4
-1.89
-1.2
-1
-0.83
-0.83
-0.67
-0.68
-0.68
-0.71
-0.71
-0.7
-0.7
Tangible Book Value per Share
0.1
-0.33
-0.71
-0.19
-0.12
-0.1
-0.11
-0.05
-0.05
-0.06
-0.08
-0.08
-0.06
-0.07
Basic Weighted Avg Shares
10
10
11
23
30
38
40
51
52
53
54
55
56
57
Sales/Revenue/Turnover
6
10
11
10
6
7
10
17
16
18
20
34
49
40
Operating Margin (%)
-53.79
-45.63
-36.95
-23.78
-28.28
-5.96
-12.41
-0.29
-2.23
-4.32
-8
-0.28
0.84
-0.41
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Net Income, GAAP
-4
-6
-6
-5
-2
-1
-1
1
-1
-1
-2
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
22.14
26.68
Profit Margin (%)
-64.86
-55.12
-50.31
-53.65
-29.09
-8.93
-13.56
3.73
-3.55
-5.25
-8.74
-0.99
0.54
-0.68
Working Capital
1
-2
-8
-5
-4
-4
-5
- -
-1
-1
-3
-2
-2
-2
LT Debt
- -
1
- -
1
- -
- -
- -
2
2
2
2
3
3
3
Total Equity
1
-3
-8
-4
-4
-4
-4
-3
-3
-3
-4
-4
-3
-4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
-2.65
- -
- -
- -
- -
-0.89
-1.97
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
2
- -
- -
LT Borrowings
- -
2
2
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
57
57
57
Market Capitalization
6
6
7

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
6
4
3
Cash, Cash Equivalents & STI
3
2
1
Accounts Receivable, Net
1
1
1
Inventories
2
1
1
Total Current Liabilities
10
6
5
Payables & Accruals
7
5
5
ST Debt
2
- -
- -
Deferred Revenue
1
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.32%
5.7%
-18.14%
Free Cash Flow
-94.2%
-101.52%
71.52%
Net Income, GAAP
-45.21%
-59.48%
-179.5%
Sales/Revenue/Turnover
20.97%
25.92%
45.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5
6
9
14
34
2025
15
16
8
10
49
2026
6
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
- -
- -
-0.01
2025
- -
- -
- -
- -
- -
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Joseph Bernard Peters
Full Time Employees
121
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
7107 Industrial Road Florence KY United States of America 41042
IPO Date
Aug 26, 2009
Business
HealthWarehouse.com, Inc. (OTCQB: HEWA) operates as a technology-driven online and mail-order pharmacy, selling and delivering prescription medications, over-the-counter (OTC) products, generic drugs, brand-name medicines, and pet prescriptions to customers across all 50 U.S. states and territories; the company provides direct-to-consumer sales, pharmacy fulfillment services for partners including high-volume telehealth providers and manufacturers, cold-chain shipping capabilities, and proprietary technology platforms focused on patient experience, operational efficiency, and scalability. Founded in 2007 and headquartered in Florence, Kentucky, HealthWarehouse.com serves individual consumers, healthcare providers, and business partners in the digital healthcare e-commerce sector, with a VIPPS-accredited pharmacy model that emphasizes competitive pricing by bypassing traditional middlemen like pharmacy benefit managers (PBMs). The company supports up to one-year prescription supplies, award-winning customer service via phone and online channels, and nationwide distribution from its primary facility at 7107 Industrial Road. In recent developments, HealthWarehouse.com reported explosive revenue growth, including 182% year-over-year sales increase to $15.7 million and net income of $228,000 in Q2 2025 driven by 495% expansion in partner services revenues, alongside positive cash flow and cash balance growth in Q3 2025 despite moderated growth from the FDA's resolution of GLP-1 drug shortages that curtailed compounded versions of tirzepatide and semaglutide; the company continues investing in technology for direct-to-patient programs, diversified partner pipelines across new product categories, and operational scalability to support manufacturers' launches.

Company News

APIChatGPT
  • HealthWarehouse.com Reports Results for First Quarter 2026

  • HealthWarehouse.com Announces Strategic Partnership with healthwords.ai

  • HealthWarehouse.com (OTCMKTS:HEWA) Stock Passes Above 50 Day Moving Average – Here’s What Happened

  • NextPlat Launches 50 State Nationwide Medication Fulfillment Capabilities, Supporting Healthcare Revenue Growth in 2026 and Beyond

  • HealthWarehouse.com Reports Full Year 2025 Results

  • HealthWarehouse.com (OTCMKTS:HEWA) Stock Price Passes Above 50-Day Moving Average – What’s Next?

  • HealthWarehouse.com Reports Results for Third Quarter 2025

  • HealthWarehouse.com Reports Results for Second Quarter 2025

  • HealthWarehouse.com Reports Results for First Quarter 2025

  • HealthWarehouse.com Reports Full Year 2024 Results

  • HealthWarehouse.com Reports Results for Second Quarter 2024

  • HealthWarehouse.com Reports Full Year 2023 Results

  • HealthWarehouse.com Reports Results for Third Quarter 2023

  • HealthWarehouse.com Reports Results for Second Quarter 2023

  • HealthWarehouse.com Reports Results for Second Quarter 2021